BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28207540)

  • 1. Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
    Liu C; Lu Q; Qu H; Geng L; Bian M; Huang M; Wang H; Zhang Y; Wen Z; Zheng S; Zhang Z
    Medicine (Baltimore); 2017 Feb; 96(7):e6124. PubMed ID: 28207540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study].
    Bian ML; Huang ML; Zhang ZY; Liu SM; Sun J; Fang F; Gu YP; Liu CD; Yao C
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):317-327. PubMed ID: 34034418
    [No Abstract]   [Full Text] [Related]  

  • 4. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of uterine leiomyoma by two different doses of mifepristone].
    Yang Y; Zheng S; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of mifepristone for the treatment of uterine leiomyomata.
    Steinauer J; Pritts EA; Jackson R; Jacoby AF
    Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.
    Esteve JL; Acosta R; Pérez Y; Campos R; Hernández AV; Texidó CS
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):202-8. PubMed ID: 22269473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: A protocol for systematic review and network meta-analysis.
    Bi C; Qiao M; Jia Y; Wang H
    Medicine (Baltimore); 2021 Oct; 100(42):e27523. PubMed ID: 34678886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
    Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
    JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
    Stolz W; Pfützenreuter N
    Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose mifepristone for uterine leiomyomata.
    Eisinger SH; Meldrum S; Fiscella K; le Roux HD; Guzick DS
    Obstet Gynecol; 2003 Feb; 101(2):243-50. PubMed ID: 12576246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
    Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
    Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
    Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone.
    Feng C; Meldrum S; Fiscella K
    Int J Gynaecol Obstet; 2010 May; 109(2):121-4. PubMed ID: 20132932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
    Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
    Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose mifepristone in medical management of uterine leiomyoma - an experience from a tertiary care hospital from north India.
    Kulshrestha V; Kriplani A; Agarwal N; Sareen N; Garg P; Hari S; Thulkar J
    Indian J Med Res; 2013 Jun; 137(6):1154-62. PubMed ID: 23852296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
    Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
    Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.